This site is intended for healthcare professionals outside the US.
US healthcare professionalsexternal-icon

Isavuconazole (drug substance: isavuconazonium sulfate) is an intravenous and oral broad-spectrum antifungal licensed in the European Union (EU) for the treatment of adult patients with:

  • -invasive aspergillosis1
  • -mucormycosis for whom amphotericin B is inappropriate1

Select your country:

Austria Flag
Austria
France Flag
France
German Flag
Germany
Italy Flag
Italy
UK Flag
United Kingdom
EU Flag
Other EU Countries
Plus Iceland, Liechtenstein, and Norway
World
Rest of world

Reference

1. CRESEMBA Summary of Product Characteristics, Basilea Medical Ltd, 2015.